Viksipin drops Ch. 0.5 mL 1% Tub-cap. 10 pcs Grotex Ltd.

$5.05

Viksipin drops Ch. 0.5 mL 1% Tub-cap. 10 pcs Grotex Ltd.

Quantity:

Description

Composition
Active substance:
1 ml of the preparation contains
Metiletilpiridinola hydrochloride 10.0 mg.
Excipients:
Gidroksipropilbetadeks 20.00 mg
10.80 mg Potassium dihydrogen phosphate
Sodium benzoate 2.00 mg
Sodium hyaluronate 1.80 mg
Sodium hydrogen phosphate dihydrate 0.36 mg
Disodium edetate dihydrate (Trilon B) 0.20 mg
Phosphoric acid 2 M to pH 4,0-5,0
Water for injections to 1 mL.
Description:
Clear or almost clear, colorless or slightly colored liquid.
Product form:
1% eye drops.
0.5 ml of a dropper tube of low density polyethylene or polypropylene.
5-tube drippers in the package of the foil film.
2, 4 or 6 pack from film and foil together with instructions for use in a stack of cardboard.
5 mL vials made of glass or of transparent brown glass, capped nozzles medical protective caps with or without protective caps, nozzles ukom- plektovannye-abutments for fingers or without them.
1 bottle together with instructions for use in a stack of cardboard.
Contraindications
Individual hypersensitivity to the drug, pregnancy, lactation, children under 18 years.
Dosage
1 %
Indications
– Treatment and prevention of inflammation and corneal burns; – treatment of hemorrhages in the anterior chamber; – treatment and prevention of bleeding in the sclera in the elderly; – retinal central vein thrombosis and its branches; – treatment of myopia complications; – diabetic retinopathy.
Interaction with other drugs
The drug should not be confused with other medicinal solutions.
Overdose
The cases of drug overdose not described.
pharmachologic effect
Pharmacological group:
Anti-oxidant agent. ATC code: S01XA.
Pharmacodynamics:
The drug reduces the permeability of the capillaries, strengthens the vessel wall, stabilizes the cell membrane, inhibits platelet aggregation, decreases viscosity of blood clotting and has antiagregatsionnym and antihypoxic action.
Pharmacokinetics:
The drug quickly into the eye tissue, where it is deposition and metabolism. In ocular tissue concentration is higher than in the blood. Detected 5 metabolites, represented dezalkilirovannymi konyungirovannymi and its conversion products. It is metabolized in the liver. Metabolites are excreted by the kidneys. Bound to plasma proteins by an average of 42%.
Pregnancy and breast-feeding
Use of the drug during pregnancy and breast-feeding period is contraindicated.
Conditions of supply of pharmacies
Prescription.
side effects
Perhaps a burning sensation, itching, transient hyperemia, local allergic reaction.
If any of these instructions side effects are compounded or you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
If necessary, the simultaneous use of other eye drop formulation was instilled last, after previous complete absorption of the drug (not earlier than after 15 minutes).
Storage conditions
At a temperature not exceeding 25 C. Keep out of reach of children.
Dosing and Administration
The drug is instilled into the conjunctival cavity 1-2 drops 2-3 times a day.
The duration of treatment depends on the course of the disease (typically 3- 30 days) and is determined by the doctor. Where indicated and good tolerability of the drug treatment can be extended to 6 months, or repeated 2-3 times a year.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

Grotex Ltd.

There are no reviews yet.

Add your review